2-Ethyl-6-methyl-3-hydroxypyridine

Independent reference data for 2-Ethyl-6-methyl-3-hydroxypyridine (CAS 2364-75-2), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.

Synonyms and trade names

emoxypin; 6-Methyl-2-ethyl-3-hydroxypyridine; 2-Ethyl-6-methyl-3-oxypyridine; RefChem:590760; 2-Ethyl-3-hydroxy-6-methylpyridine; 2364-75-2; 2-ethyl-6-methylpyridin-3-ol; Emoxypine; Emoxipine; Epigid; 2-Ethyl-6-methyl-3-hydroxypyridine; Emoxipin; 2-Ethyl-6-methyl-3-pyridinol; 3-Pyridinol, 2-ethyl-6-methyl-; Epygid; MFCD00462409

GHS hazard classification

Reported hazard statements	H315 (100%), H319 (100%)

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

What the public record says

2-Ethyl-6-methyl-3-hydroxypyridine · CAS 2364-75-2 · C8H11NO. UNII V247P5H4E1.

Source: PubChem / Wikidata; the batch COA governs where values differ.